Published on 10 May 2024 on GuruFocus.com via Yahoo Finance
Health Catalyst Inc (HCAT) Q1 2024 Earnings: Modest Revenue Growth and Strategic Financial ...
Revenue: Reported $74.7M, slightly below the estimate of $75.8M.Net Loss: Improved to $(20.6M) from $(33.2M) year-over-year, indicating a 38% reduction in losses.Gross Margin: Increased to 39% from 38% year-over-year, reflecting a 1% rise in gross profit to $29.3M.Adjusted EBITDA: Totaled $3.4M, down from $4.2M in the previous year.Future Guidance: Reiterated full-year revenue forecast between $304M and $312M and Adjusted EBITDA between $24M and $26M.Operational Highlights: Maintained strong bookings metrics including dollar-based retention rate and net new DOS Subscription client additions.
Warning! GuruFocus has detected 3 Warning Signs with HCAT.
